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T  lymphocytes  have  been  shown  to  react  with  antisera  directed  against  cross- 
reactive idiotypes  (1,  2).  This observation  lead to the hypothesis that T  cells express 
Igh-I linked gene products in association with antigen binding molecules (3). Failure 
to detect isotypic determinants characteristic of serum immunoglobulin  (4) suggested 
that  T  cells may express unique immunoglobulin-like molecules that have their own 
constant  regions.  Cell  lines secreting a  monoclonal T  cell product specific for sheep 
erythrocytes (5) and one specific for arsonate (Ars) 1 (6) have supported the conclusion 
that some T  cells use heavy chain-like molecules as antigen receptors. 
A  group of T  cell-specific alloantigens  are linked  to the irnmunoglobulin  locus on 
chromosome 12 in the mouse. The region encoding these antigens has been tentatively 
designated  IgT-C  (7).  The  existence  of a  gene  complex,  downstream  from  Igh-1, 
coding  for  a  family  of T  cell  isotypes  has  been  proposed  (7,  8).  The  first  gene(s) 
described,  Tsu d  (9),  was  mapped  to  this  region  using  recombinant  inbred  and 
recombinant  congenic lines  (7).  The Tsu d antigen  has  been  proposed  to be a  T  cell 
constant region gene product because of the ability of antiserum directed against Tsu d 
to polyclonally trigger suppressor cells for T-dependent  antigens  (10). The suppressor 
cells induced obey the rules of genetic restriction  (11) 2 established for idiotype-specific 
regulatory cells  (12). Antiserum also blocks binding of anti-Ars IdX Ts2 cells (I3) to 
their idiotype  (14).  The position of the gene complex distal  to the heavy chain  locus 
(7)  is  suggestive  evidence  that  these  may  be  T  cell  heavy  chain-like  molecules.  A 
second  T  cell  alloantigen,  Tind d,  was  found  in  the  course  of attempts  to  make 
monoclonal anti-Tsu d. The use of a panel of Igh-1 recombinant mice limited the gene 
coding for this determinant  to a region of chromosome 12 (15) closely linked to Tsu d. 
This  study  describes  the  use  of two  monoclonal  lines  secreting  antibody  against  a 
third  T  cell-specific  alloantigen,  Tthy  d.  Tthy  d,  in  contrast  to  Tsu d  or  Tind d,  is 
preferentially  expressed  on  thymocytes.  Use  of Igh-1  recombinant  lines  shows  the 
gene(s) coding for this antigen (s) is closely linked to Tsu d (7,  15). The frequency of the 
cells in the thymus (30%)  and periphery  (1%), which express this antigen, stimulated 
the hypothesis that Tthy  d may be a third isotype for T  cell receptors and that a switch 
mechanism from expression ofTthy  d to Tsu d or Tind d may parallel T  cell maturation. 
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Materials and Methods 
BALB/c AnN mice were purchased from Charles River Breeding Laboratories, Inc. (Wil- 
mington, Mass).  All other animals were bred in our laboratories at Tufts from lines developed 
elsewhere. C.AL-20 (Igh-1 a) animals, congenic to BALB/c except for an undetermined number 
of genes linked to immunoglobulin,  were developed by M. Potter at the National Institutes of 
Health  (Bethesda,  Md.).  BAB/14,  developed  by  L.  A.  Herzenberg,  Stanford  University 
(Stanford, Calif.)  are congenic to BALB/c and have recombination events in the cluster of 
IgH-V genes resulting in an Igh-V  a Igh-C  b haplotype. The C.B.AL-1  (Igh-V  a, IgH-C  b, Tsu  a-, 
Pre-la), C.B.AL-2  (Igh-V  a,  Igh-C  b,  Tsu  a-,  Pre-l¢),  and  C.B.AL-4  (Igh-V  a,  Igh-C  b,  Tsu  a-, 
Pre-1 ~) mice are recombinant Igh-1  strains derived from a cross of C.AL-20 and BAB/14 (16). 
The method of typing for Tsu  a has been described (7, 8). 
Monoclonal anti-Tthy  a (Clone 1711C6) was produced using a modification of the immuni- 
zation procedure described for  Tind  a  (15).  Briefly,  BALB/c animals were immunized with 
C.AL-20 T  cells  activated with concanavalin A  (Con A).  Spleen cells  that  formed the least 
dense bands from a discontinuous  bovine serum albumin gradient were used for immunization 
(9). Animals received  107 cells in a single immunization 3 d  before killing. Spleen cells were 
fused  (17) with P.3U1  tumor cells (18) using polyethylene glycol and plated in selective media 
supplemented with  l  ×  I0  -4 M  hypoxanthine, 4 ×  10  -v M  aminopterine, and  1.6 ×  10  -5 M 
thymidine (19). The frequency of fusion was  10% and cells were subcloned into nonirradiated 
C.B~20 thymocytes (106/well)  with an efficiency of 65%. Screening for positive clones used a 
cell  surface radioimmunoassay (Sprull, G. M.,  L.  Riendeau, A.  Finnegan, and F.  L.  Owen, 
manuscript in preparation). Briefly, either BALB/c or C.AL-20 Con A-activated T  cells were 
plated  into 96-well  microtiter plates,  and cell  monolayers were  fixed  with  glutaraldehyde. 
Positive clones were those that secreted antibody binding to C.AL-20 and not to BALB/c when 
a second step l~SI-labeled goat anti-mouse IgM was added as a developing reagent (20). 
Monoclonal anti-Tthy  (b),  from  clone 208IE6,  arose  as  a  deliberate effort  to  produce 
antibody against thymocytes. An alternate immunization  procedure was initiated. BALB/c nu/ 
nu mice (Charles River Breeding Laboratories, Inc.) were immunized intraperitoneally  with 10  v 
C.AL-20 thymocytes on days 10 and 3 before fusion of immune spleens with P.3U 1 tumor cells. 
The fusion frequency was 3%, and the one selective  clone (208IE6)  was subcloned by limiting 
dilution into C.AL-20 thymocyte feeder cells. The subcloning  efficiency was 2% when two cells 
per  well  were  plated.  The  resulting IgGlk-secreting line was  obtained by screening in the 
cellular immune assay described above using either BALB/c or C.AL-20 thymocytes as targets 
and 125I- goat anti-IgG1 (MOPC-21) as the developing reagent. 
The expression of Tthy  a on thymocytes was confirmed in a visual dye exclusion cytotoxicity 
test.  A two-stage antibody and complement-mediated lysis was performed by incubating 5 × 
l0  s thymocytes from either BALB/c or C.AL-20 animals at 37°C for 30 rain with 10/~l of tissue 
culture supernatant from monoclonal lines. This was followed by an incubation at 37°C for 45 
min with 25 pl of 1:12 diluted selected rabbit complement. Dead cells were evaluated by the 
inability to exclude eosin red.  Data are expressed  as cytotoxic index (CI); the arithmetic mean 
+  SE of duplicate determinations was  adjusted for complement controls. CI is equal to the 
percent of dead cells with antibody-C'/percent of dead cells with anti-BAT-C'. Experiments 
were executed in a double blind study to minimize bias. Data are expressed  as percent of lysis 
with antibody and complement minus percent oflysis with complement alone. The complement 
background varied with the strain used and was 25 +  5% on the C.AL-20 thymocytes. 
Absorption experiments were used to estimate the Lyt phenotype of the cells expressing the 
antigen. Tissue culture supernatant from clone  17IIC6 (40 /~1) was  incubated with limiting 
numbers of thymocytes, bone marrow cells, lymph node cells, or antibody-treated cell popula- 
tions. Anti-Lyt-1.2 was a monoclonal antibody purchased from New England Nuclear (Boston, 
Mass.),  and monoclonal anti-Lyt-2.2 (21) was the generous gift of P. D. Gottlieb, Austin, Tex. 
Results 
Tthy  a is expressed on thymocytes or recombinant mice with the Tind  a+ phenotype. 
Thymocytes of the  C.AL-20 strain  (Igh-I  a)  can  be  lysed with  anti-Tthy  a  (17IIC6) 
monoclonal (IgMk) antibody and selected rabbit complement. BALB/c (Igh-1  a)  and 54  Tthyd--TtIYMOCYTE  ALLOANTIGEN  LINKED  TO  Igh-1 
BAB/14  (Igh-1 b) thymocytes are not sensitive to the effect of ant i-Tthy d. Three Igh-1 
recombinant  strains,  constructed  by  crossing  C.AL-20  and  BAB/14  animals,  also 
failed  to express  the Tthy  a antigen  in a  detectable  way.  Since  the immunoglobulin 
genes  of the  three recombinant  animals,  C.B.AL-1,  C.B.AL-2,  and  C.B.AL-4,  have 
been characterized and have been typed as negative for Tsu a (7), the failure to express 
Tthy  d  indicates  that  the  gene(s)  coding  for  Tthy  d  is  closely  linked  to  Tsu d.  The 
recombinant  mice  limit  the  position  of  the  gene  coding  for  this  determinant  to 
chromosome I2.  It must be downstream from Igh-Dex and upstream from a  recom- 
bination event between Tsu a and H(Igh)  (see map inset on Table  I). Antibody and 
complement lyse  15-35%  of thymocytes from C.AL-20 animals  (Table I)  but  do not 
lyse  a  detectable  number of T  cells  from  lymph  node or spleen  (data  not  shown). 
Estimates of the total frequency of cells expressing this antigen may be a reflection of 
cell surface density, and the number of cells that actually are Tthy d+ could be much 
higher (Table I). Other strains not listed in Table I were typed Tthy  a+, A/J, AKR/J, 
or Tthy  d-, C57BL/6J,  and CBA/Tu. 
The Tthy  d antigen  is restricted  to the T  lymphocyte lineage  and  is preferentially 
TABLE  I 
Strain Distribution of Tthy a Limits the Gene Coding  for This Determinant to IgT-C 
Strain 
Anti-  Anti-  Anti-  Phenotype*  H (Igh)  Pre- 1 
Tthy  d° (2'  BAT  (2'  BSA (2'  IgH-V  Igh-(2  Tsud(Tind d, 
Tthy d) 
C.AL-20  23:}:  94  i  d  d  d  (d,d)  -  a 
BALB/C  :3  83  1  a  a  -  (-,--)  +  0 
BAB/14  1  79  1  a  X  b  -  (-,-)  X  -  c 
C.B.AL- 1  1  78  1  d  X  b  -  (-,-)  -  a 
C.B.AL-2  3  69  1  d  X  b  -  (-,-)  -  c 
C.B.AL-4  2  85  1  d  X  b  -  (-,-)  -  c 
* Monoclonal  antibody  from  tissue  culture  supernatant  (10 #1/5  ×  10:'  thymocytes)  was  incubated  with 
cells in a  96-well microtiter plate at 37°C for 30 min, followed by a 45-rain  incubation  at 37°C, followed 
by a  45-min  incubation  at  37°(2  with  1-12  dilute selected  rabbit  complement.  Duplicate  samples were 
observed visually. 
:~ The  data  shown  are  for  the  cytotoxic  index  of one  experiment.  The  grand  arithmetic  mean  of  the 
difference  between C' and anti-Tthy a was determined  for  10 separate experiments for C.AL-20  (25 +  2~7,) 
and  BALB/c  (2 +  1%), P<  0.001. 
×  6o 
~z  5e 
u  4o 
x  30 
20 
>-  ~[2 
¢.2  10_ 
I  I  ]  ~ 
0.5  I  2.5  5 
NUMBER  OF" ABSORBING  CELLS  x  IO -6 
Fro.  1.  Absorption  of anti-Tthy d with  thymocytes  (0)  is  10-fold  more efficient  than  absorption 
with lymph node (O), or marrow (D) ceils. Absorption was done by incubating limiting dilutions of 
cells with 40 #1 of tissue euhure  supernatant  from clone  17II(26 at 4°(2 for  1 h. Cells were removed 
by centrifugation  and remaining  tissue culture supernatant  containing  antibody  was used to treat 
C.AL-20 thymocytes as described in Table  I. OWEN  ET  AL.  55 
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FIG.  2.  Anti-Tthy  d recognizes a thymocyte with the Lyt-l+2+3+ phenotype. Thymocytes (5 X  107/ 
500 ml) were divided into three parallel cell groups. Group A was treated with tissue culture media 
(©);  group B with 5 ~1 of monoclonal anti-Lyt 2.2 (O); and group C with 20 p,l of monoclonal anti- 
Lyt-1. ~ (l~). Cells were incubated for 30 min at 37°C, pelleted by centrifugation, and resuspended 
in  1-12 dilute rabbit complement for 45 rain at 37°C (percent of dead cells was A, 12%; B, 48%; C, 
67%).  Washed  cells  were  used  at  limiting  dilutions  to  absorb  anti-Tthy  d  from  tissue  culture 
supernatant of clone  171IIC6.  Controls, using anti-Tthy  d from tissue culture supernatant of clone 
17IIIC6. Controls, using anti-Tthy  d and C', lysed 64% of the cells, C' alone, 30%, and rabbit anti- 
BAT and C', 93%. The graph is plotted as cytotoxic index (see Materials and Methods). Standard 
deviations on duplicate determinations were <2% and were not plotted. 
TABLE  II 
Anti-Tthy a Is a  New Specificity  Not Identified  by Monoclonal 
Anti- Tind d or Anti- Tsu a 
Percent dead 
Antibody  C' Preblocking  cells 
reagent* 
-+SD 
--  +  --  13.7 -+  1 
Anti-Tthy  a (17IIC6):~  +  --  36.0 ±  3 
Anti-Tthy(b)  a (208IE6)  +  --  22.3 .+  1 
Anti-Ttby  a (17IIC6)  +  Anti-Con A (71A7)  37.5 :!: 4 
Anti-Tthy  a (1711C6)  +  Anti-Tind  d (9IIIA2)  39.0 .+ 2 
Anti-Tthy  a (171IC6)  +  Anti-Tsu  a (13IIIB4)  33.0 .+  1 
Anti-Tthy  d (17IIC6)  +  Anti-Tthy  a (17IIIC6)  46.0 .+  11 
Anti-Tthy  a (171IC6)  +  Anti-Tthy(b)  a (2081E6)  43.0 ±  8 
* Antibody  used  for  preblocking  was  20  /LI  of  tissue  culture  supernatant. 
Antibody was preincubated with cells for  1 h  at 37°C and left in during a 
second incubation with anti-Tthy  d and complement. 
:~ Tissue culture supernatant (10 p,l/5 ×  l0  s thymocytes) was determined to be 
at the concentration for optimum lysis (experiments not shown). 
expressed on  thymoeytes. Limiting dilution  absorption  experiments of Tthy  d with 
thymocytes,  lymph  node  cells,  and  splenic  T  and  B  cells  (Fig.  1)  suggest  that 
thymocytes express this marker with a  cell density and/or total frequency 10 times 
greater than that of other lymphoid ceils.  In contrast, bone marrow cells do remove 
some  antibody,  suggesting  the  antigen  may  be  on  a  very  immature  T  cell.  This 
confirms our negative attempts to lyse peripheral cells with antibody and complement. 
The Lyt phenotype of thymocytes expressing this determinant was examined by 
absorption.  Thymocytes were treated with  monoclonal anti-Lyt-l.1  or anti-Lyt-2.2 56  Tthyd--TttYMOCYTE  ALLOANTIGEN LINKEI) TO Igh-1 
(21)  and complement, and recovered cells were used to absorb anti-Tthy  d.  Limiting 
dilutions  of cells  (0.5-5.0  ×  106) were  used  to  absorb  tissue  culture  supernatant. 
Absorbed or unabsorbed antibody was used to lyse thymocytes. We conclude that the 
Lyt-1 +2+3 + thymocyte expresses Tthy  d because either anti-Lyt-1.2 or anti-Lyt-2.2 and 
complement deplete the cell capable of adsorbing anti-Tthy  d antibody (Fig.  2).  It is 
possible  that  Lyt-l+,2-3  -,  Lyt-l+2+3  +,  and  Ly-l-2+3  + cells  all  express  Tthy  d.  Our 
frequency estimates are based on the use of a complement that is cytotoxic for 25% of 
thymocytes. If that cell lysis was nonspecific, then the actual number of positive cells 
could be significantly greater. 
Tthy  d is a  unique specificity not recognized by monoclonal antibodies specific for 
Tind d (9IIIA2)  (15)  or Tsu d (13IIIB4)  (unpublished  observation). Thymocytes were 
treated with anti-Tthy  d (clone  17IIC6) or anti-Tthy(b)  °  (clone 208IE6)  and comple- 
ment  (Table II). Pretreatment  of thymocytes with nonlytic IgG1K monoclonal anti- 
bodies  against  Con  A  (71A7)  (21),  Tind  d  (9IIIA2)  (16),  or Tsu d  (13IIIB4)  did  not 
block lysis with anti-Tthy  d (17IIC6). Clone 208IE6 must recognize a similar specificity 
to that  recognized by  17IIC6. The cytotoxicity observed with  the two antibodies  is 
not additive and the cell populations seem identical  (data not shown). Clone 208IE6 
has tentatively been named anti-Tthy(b) d pending biochemical identification.  Anti- 
body from clone 208IE6 has been typed IgGlk but is a complement-fixing molecule. 
Discussion 
Evidence for the expression of antigen  binding receptors on the surface of thymo- 
cytes is indirect.  Most  of the lymphocytes in  the thymus are nonfunctional  prothy- 
mocytes (22).  A  few cells corresponding to the low density cortisone-resistant  popu- 
lations  do respond  to  lectins  and  alloantigens  when  the  unresponsive population  is 
removed  (23).  The most  convincing argument  that  antigen  receptors exist  for thy- 
mocytes has arisen  from allogeneic radiation  chimeric mice. It has been shown  (24, 
25)  that  T  cells,  before their exit  from the  thymus,  are  influenced  to recognize self 
histocompatibility  antigens  in  association  with  nominal  antigen.  Many  hypotheses 
have attempted  to explain  this apparent  "imprinting"  involving either thymic epi- 
thelium (26), the thymic nurse cell (27), or a nonthymic hematopoietic cell (28). Some 
studies  would  suggest  this  imprinting  may actually  occur earlier  in  hematopoiesis. 
When nu/nu lymphocytes were transferred into recipients, the same restrictions (29) as 
those attributed  to influence of a  thymic microenvironment were observed. If early 
thymocytes or prothymocytes in the bone marrow can recognize self- or alloantigens 
(30),  then  it  is  probable  that  antigen-specific  receptors  modulate  this  recognition. 
However, in contrast to mature, post-thymic T  cells (31-33),  thymocytes have never 
been shown to directly bind to cell monolayers or antigen. 
We have previously reported two alloantigens, Tsu  d and Tind d, that may represent 
isotypes of T  cell receptors (15).  If this is the case, it is surprising that neither Tsu d (9) 
nor Tind  d (15)  is expressed in a  detectable way on the majority of thymocytes. Tsu  d 
can be detected in the thymus only when cells are separated by density sedimentation 
to enrich for the least dense cells (9). Tind  a in contrast has not been found on this cell 
population  or any other in  the thymus in our visual  fluorescent microscopy experi- 
ments.  The  apparent  lack  of these  two  antigens  in  the  thymus  gave  rise  to  the 
experiments summarized here. Tthy  a appears to be another T  cell-specific alloantigen 
coded for by a  gene(s) closely linked to Tsu d and Tind d but preferentially expressed OWEN ET AL.  57 
on thymocytes (Table I). It seems possible that Tthy  d represents a third isotype of an 
antigen-binding moiety, and that selective pressures during T  cell maturation induce 
an  isotype switch  from  Lyt-l+2+3  + thymocytes and  the  Lyt-l+2-3  -  or Lyt-l-2+3  + 
splenic  cells.  The  frequency  of Tthyd-positive  cells  (estimated  by  antibody  and 
complement-mediated  lysis)  is  a  minimum  of 30%  of the  total  thymocytes. This 
implies that many, if not all, of the Lyt-l+2+3  + thymocytes express Tthy  a. However, 
absorption experiments with lymph node or splenic cells indicate Tthy  a is undetectable 
on Lyt-l+2-3  -  or Lyt-l-2+3  + "mature cells." In contrast, Tsu  a is present on a limited 
number  of thymocytes corresponding to  the  low  density,  functionally reactive  (9) 
population and also on the Lyt-l-2+3  + splenic T cells (7, 9, 10). In comparison, Tind  a 
is present on a low frequency of Lyt-1+2-3  -  splenic T  cells (15). 
An isotypic switching mechanism might be an adaptive mechanism for control of 
self-recognition interactions. An early, nonfunctional precursor T  cell in the thymus 
may  be  impotent  because  its  isotype  is  one  that  is  not  released  effectively,  is 
enzymatically degraded easily, and/or is characterized by low affinity for antigen. 
This would be an advantage  intrathymically if low affinity for self-recognition is a 
prerequisite for extrathymic trafficking. A  post-thymic shift to an isotype associated 
with  higher  avidity  for  antigen  and  a  functionally  distinct  role  would  allow  a 
functional cell to release a product capable of more efficiently homing to its target. If 
there are multiple isotypes of T  cell receptors and  if those receptors are released in 
either an identical or post-translationally modified form to serve as soluble mediators, 
then it is probable that different isotypes may have different effector functions. The 
ability to bind antigen and to express molecules serologically cross-reactive with the 
major serum cross-reactive idiotypes is a property associated with both helper factors 
(33) and suppressor factors (34). The antigen-binding site alone should therefore not 
be enough to determine functionality of a T  cell product. The isotype switch model 
would provide a mechanism for preservation of the same T  cell "idiotype" on helper 
and  suppressor  cell  isotypes, permitting  regulation  of the  balance  of the  immune 
response by a  closed but  fluid loop of idiotype anti-idiotype interactions  (35).  The 
switch  mechanism  proposed here has  many similarities  with  the change  in  surface 
immunoglobulin  isotypes characteristic of virgin- and  antigen-triggered B  lympho- 
cytes (36). A  sequential  genetic rearrangement of the DNA in developing cells (37) 
has  provided  a  mechanistic  answer  to  this  phenomenology. A  similar  mechanism 
might be used by T  cells.  The close proximity of the genes coding for Tsu  a, Tind  d, 
and Tthy  d to the immunoglobulin  locus could allow these T  cell genes to combine 
with  B  cell antigen-specific variable region  genes.  Alternatively, T  cells may have 
their own unique but evolutionarily related variable region genes, utilizing a similar 
genetic rearrangement. The finding that B cell J  segments are not rearranged (8, 38), 
and  that  the/~ gene is not deleted  (38)  in T  cell lines, makes the second possibility 
attractive;  However, other post-translational  mechanisms  for conservation of B cell 
variable region genes on T  cell receptors are equally plausible. 
The model outlined above suggests  that  the most  mature T  effector cells should 
express  nonoverlapping isotypes.  Our  observations  show  that  Tsu  d and  Tind  a  are 
preferentially expressed on cells with different Lyt phenotypes. One might expect to 
see a  spectrum of cells expressing a  progression of T  cell isotypes as the cells move 
further away from the thymic influence. 
The foregoing hypothesis makes the assumption  that  Tsu  d, Tind  d, and 'Tthy  d are 58  Tthya--THYMOCYTE  ALLOANTIGEN LINKED TO  Igh-! 
antigen-binding gene products.  That  fact  has been  documented  for the monoclonal 
Ars  Tsl  factor.  3  It  is  possible  that  this  series  of T  cell  alloantigens  is  a  group  of 
differentiation antigens parallel to the Lyt series, but the association of Tind  a with a 
suppressor factor makes this unlikely. In either event,  the region of chromosome  12 
tentatively designated IgT-C appears to encode a series oft  cell-specific gene products 
of fundamental importance to T  cell activation and maturation. 
Summary 
Tthy  d is an  alloantigen coded for by a  gene(s)  near the immunoglobulin locus on 
chromosome  12 in the mouse.  This T  cell-specific antigen may be the third member 
of a  family of antigen receptors on T  cells encoded by a  cluster of genes in the IgT-C 
region. This antigen is preferentially expressed on thymocytes in contrast to Tind  d or 
Tsu d that  are expressed on  peripheral T  cells. The  hypothesis that  T  cell receptors 
undergo a  switch in surface isotype upon maturation is discussed. 
We thank John Fontana for valuable technical assistance, Henry Wortis for access to reagents 
used to isotype our monoclonals, and R. Riblet for access to Igh-1 recombinant mice. 
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